US2014187580A1PendingUtilityA1

Spin Traps and Spin Labels for the Treatment of Rectal Hemorrhoids

Individually held — no corporate assignee on recordPriority: Nov 7, 2010Filed: Feb 4, 2014Published: Jul 3, 2014
Est. expiryNov 7, 2030(~4.3 yrs left)· nominal 20-yr term from priority
A61P 9/14A61P 31/22A61P 35/00A61P 9/00A61P 25/06A61P 29/00A61K 47/38A61K 9/06A61K 31/15A61P 1/08A61P 25/00A61K 9/0095A61K 31/445A61K 31/45
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Nitrone, nitroso, and nitroxide spintraps and spin labels and their reduction products are claimed for the treatment of rectal hemorrhoids and rectal fissures.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for the treatment of rectal hemorrhoids or rectal fissures with a spin trap or a spin label. 
     
     
         2 . A method comprising treatment of rectal hemorrhoids or rectal fissures where the spin label is TEMPO or a pharmacologically-active derivative including 4-hydroxy-TEMPO (TEMPOL), 4 aminotempol, (2,2,6,6-tetramethyl-1-piperidinyl-1-oxyl), (2-(2,2,6,6-Tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl)triphenylphosphonium chloride monhydrte (Mito TEMPOL) and/or their reduced derivatives TEMPO-H, TEMPOL-H, or mito-TEMPOL-H, as well as their pharmacologically-active esters, amides and ethers. 
     
     
         3 . A method for the treatment of the above where the nitroxide, nitrone, or nitroso compound is phenylbutylnitrone, or its hydrolysis product, 2-methyl, 2-nitrosopropane. 
     
     
         4 . A method comprising treatment of rectal hemorrhoids and rectal fissures where the pharmacologically-effective dose is 0.01-1000 mg per day of a pharmacologically-active nitroxide spin-trap or spin label or their equivalent hydroxylamine or other reduced derivatives administered by suitable means such as orally, sublingually, transrectally, intramuscularly, intravenously, or subcutaneously.

Join the waitlist — get patent alerts

Track US2014187580A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.